Strategic applications of heterocyclic compounds in pharmaceutical innovation: a business perspective

Strategic applications of heterocyclic compounds in pharmaceutical innovation: a business perspective Yan Dong Department of Immunology and Laboratory Medicine, Jiangsu Key Laboratory of Laboratory Medicine, School of Medicine, Jiangsu University Zhenjiang, China Jindong Dai Department of Immunology and Laboratory Medicine, Jiangsu Key Laboratory of Laboratory Medicine, School of Medicine, Jiangsu University Zhenjiang, China Yuerong Zou Department of Immunology and Laboratory Medicine, Jiangsu Key Laboratory of Laboratory Medicine, School of Medicine, Jiangsu University Zhenjiang, China Kanagaraj Rajalakshmi School of Chemistry and Chemical Engineering, Jiangsu University Zhenjiang, China Natarajan Kiruthiga Department of Pharmaceutical Chemistry, KMCH College of Pharmacy Coimbatore, Tamil Nadu, India P. Balaji Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies Chennai, Tamil Nadu, India Dongwei Zhu Department of Immunology and Laboratory Medicine, Jiangsu Key Laboratory of Laboratory Medicine, School of Medicine, Jiangsu University Zhenjiang, China

The heterocyclic compound is one of the finest spanned backbones for developing most innovative agents in the pharmaceutical industry. These adaptable molecules have played an important role in the discovery of therapeutic agents of a wide range, including antibiotics, anticancer drugs and antivirals. The role of heterocyclic chemistry in pharmaceutical innovation is thus one that extends beyond mere structural complexity but contributes significantly to improved therapeutic index, and in doing so stimulates economic activity in the field. The medicinal significance of heterocycles, their role in drug discovery, and their commercial prospects are discussed in the Research article. It explores types of heterocyclic compounds, its historical importance, influence on the world health and market trends delivering its industrial usage. Synthetic challenges, regulatory hurdles, and sustainability concerns are discussed in tandem with future opportunities that may arise from advancements in green synthesis and artificial intelligence (AI)-driven drug discovery. This study emphasizes the transformative potential of heterocyclic compounds in modern medicine by connecting their scientific advancements to business strategies.
4 28 2026 1780357 10.3389/fchem.2026.1780357 1 10.3389/crossmark-policy frontiersin.org true National Natural Science Foundation of China 10.13039/501100001809 China Postdoctoral Science Foundation 10.13039/501100002858 https://creativecommons.org/licenses/by/4.0/ 10.3389/fchem.2026.1780357 https://www.frontiersin.org/articles/10.3389/fchem.2026.1780357/full https://www.frontiersin.org/articles/10.3389/fchem.2026.1780357/full J. Food Quality Ali 19 3930112 2022 Lipopeptide biosurfactants from Bacillus spp.: types, production, biological activities, and applications in food 10.1155/2022/3930112 Open Med. Chem. J. Amin 16 e187410452209010 2022 A review on the medicinal and industrial applications of N-containing heterocycles 10.2174/18741045-v16-e2209010 Synth. Commun. Arabmarkadeh 51 880 2021 Nanomaterials: catalysis in synthesis of highly substituted heterocycles 10.1080/00397911.2020.1864646 J. Clean. Prod. Bamakan 302 127021 2021 Blockchain-enabled pharmaceutical cold chain: applications, key challenges, and future trends 10.1016/j.jclepro.2021.127021 Heterocyclic chemistry, new Age international 2020 Bansal 2020 Curr. Phys. Chem. Baranwal 13 2 2023 A review on the synthesis and pharmacological activity of heterocyclic compounds 10.2174/1877946813666221021144829 J. Med. Chem. Bhutani 64 2339 2021 US FDA approved drugs from 2015–June 2020: a perspective 10.1021/acs.jmedchem.0c01786 Med. Chem. Biswas 20 369 2024 Nitrogen-fused heterocycles: empowering anticancer drug discovery 10.2174/0115734064278334231211054053 Chem. Heterocycl. Compd. Chebanov 59 386 2023 Heterocycles on the crest of microwaves and ultrasonics in the Institute for single Crystals of national academy of sciences of Ukraine: chemistry and history 10.1007/s10593-023-03207-w Pathology-Research Pract. Chen 272 156092 2025 Exploring alkaloids and flavonoids from natural sources: emerging natural agents for inhibiting cervical cancer progression through apoptosis induction, anti-inflammatory effects, and oxidative stress reduction 10.1016/j.prp.2025.156092 Food Safety Dai 38 e12555 2018 Analysis of volatile compounds of Tremella aurantialba fermentation via electronic nose and HS-SPME-GC-MS 10.1111/jfs.12555 Results Chem. Das 5 100871 2023 PEG-200: a versatile green solvent assisted catalyst-free one-pot three-component synthesis of functionalised N-amino-3-cyano-2-pyridone 10.1016/j.rechem.2023.100871 Molecules de La Torre 26 627 2021 The pharmaceutical industry in 2020. An analysis of FDA drug approvals from the perspective of molecules 10.3390/molecules26030627 J. Heterocycl. Chem. dos Santos 58 2226 2021 Heterocyclic compounds as antiviral drugs: synthesis, structure–activity relationship and traditional applications 10.1002/jhet.4349 Synthesis Federsel 54 4257 2022 Taking the green road towards pharmaceutical manufacturing 10.1055/a-1752-5471 Artif. Intell. Life Sci. Gadiya 3 100069 2023 Pharmaceutical patent landscaping: a novel approach to understand patents from the drug discovery perspective 10.1016/j.ailsci.2023.100069 J. Heterocycl. Chem. Gönül 60 86 2023 Antioxidant and cytotoxic properties of some new dipeptide‐indole conjugates 10.1002/jhet.4564 Chem. Soc. Rev. Han 54 367 2025 Development of the design and synthesis of metal–organic frameworks (MOFs)–from large scale attempts, functional oriented modifications, to artificial intelligence (AI) predictions 10.1039/d4cs00432a RSC Advances Heravi 10 44247 2020 Prescribed drugs containing nitrogen heterocycles: an overview 10.1039/d0ra09198g Optimized continuous bioproduction of ectoine from carbon dioxide and industrial contaminants using Guyparkeria halophila Huang-Lin 2026 10.1016/j.jece.2026.122338 Results Chem. Kabir 4 100606 2022 A review on biological and medicinal impact of heterocyclic compounds 10.1016/j.rechem.2022.100606 Polycycl. Aromat. Compd. Kapoor 45 136 2025 Drugs and their mode of action: a review on sulfur-containing heterocyclic compounds 10.1080/10406638.2024.2392781 Food Chem. Khan 368 130854 2022 Mitigation of heterocyclic amines by phenolic compounds in allspice and perilla frutescens seed extract: the correlation between antioxidant capacities and mitigating activities 10.1016/j.foodchem.2021.130845 Chem. Rev. Kopf 122 6634 2022 Recent developments for the deuterium and tritium labeling of organic molecules 10.1021/acs.chemrev.1c00795 Anti-Cancer Agents Med. Chemistry-Anti-Cancer Agents Kumar 22 3196 2022 Heterocyclic compounds: importance in anticancer drug discovery 10.2174/1871520622666220404082648 Crit. Rev. Food Sci. Nutri. Li 65 5218 2025 Functionalized metal-organic frameworks with biomolecules for sensing and detection applications of food contaminants 10.1080/10408398.2024.2406482 Flavour Fragrance J. Li 39 271 2024 Identification of characteristic volatiles of Zhenjiang aromatic vinegar using HS-SPME-GC/MS coupled with multivariate analysis 10.1002/ffj.3796 J. Med. Chem. Marshall 67 11622 2024 An update on the nitrogen heterocycle compositions and properties of US FDA-approved pharmaceuticals (2013–2023) 10.1021/acs.jmedchem.4c01122 Curr. Org. Chem. Martins da Silva 28 1023 2024 The chemistry of aldehydes and ketones in the synthesis of heterocycles-historical reactions with a new and green perspective 10.2174/0113852728295534240223044735 J. Photochem. Photobiol. A Chem. Mathew 434 114237 2023 Carbon dots from green sources as efficient sensor and as anticancer agent 10.1016/j.jphotochem.2022.114237 Tetrahedron Lett. Mohlala 61 151796 2020 Synthesis of highly functionalised 5-membered ring fused pyrimidine derivatives using anisocyanide-based one-pot, three component reaction 10.1016/j.tetlet.2020.151796 Front. Chem. Mohlala 12 1469677 2024 Highlighting multicomponent reactions as an efficient and facile alternative route in the chemical synthesis of organic-based molecules: a tremendous growth in the past 5 years 10.3389/fchem.2024.1469677 Molecules Mohlala Rl 26 5493 2021 Synthesis of 6-membered-ring fused thiazine-dicarboxylates and thiazole-pyrimidines via one-pot three-component reactions 10.3390/molecules26185493 Pharm. Dev. Technol. Mohtashami 25 116 2020 Pharmaceutical implants: classification, limitations and therapeutic applications 10.1080/10837450.2019.1682607 J. Natural Products Newman 83 770 2020 Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019 10.1021/acs.jnatprod.9b01285 Clin. Pharmacol. and Ther. Nugent 117 1627 2025 Confirmatory evidence used in non‐oncologic rare disease new molecular entity marketing applications approved by FDA, 2020–2023 10.1002/cpt.3630 Al-Azhar J. Pharm. Sci. Omar 62 39 2020 Review article; anticancer activities of some fused heterocyclic moieties containing nitrogen and/or sulfur heteroatoms 10.21608/ajps.2020.118375 Green Chem. Ou 27 11882 2025 Heterogeneous Fe single-atom catalysis for C2–H amidation of pyridine/quinoline N-oxides: streamlined synthesis of pharmaceutical scaffolds 10.1039/D5GC03797B Environ. Sci. Pollut. Res. Pai 29 35518 2022 A critical look at challenges and future scopes of bioactive compounds and their incorporations in the food, energy, and pharmaceutical sector 10.1007/s11356-022-19423-4 Vaccine Palache 64 127747 2025 The IFPMA IVS seasonal influenza vaccine dose distribution survey 2022–2023: evidence of the need for committed national investment in and uptake of seasonal influenza vaccination 10.1016/j.vaccine.2025.127747 J. Heterocycl. Chem. Parthiban 60 1210 2023 Bi‐tailed n‐cationic surfactant promoted green synthesis of 2‐amino‐5‐oxo‐4‐alkyl‐4, 5‐dihydropyrano [3, 2‐c] chromene‐3‐carbonitrile derivatives via multicomponent reaction 10.1002/jhet.4663 Cancers Pfab 13 3193 2021 Repurposing of antimicrobial agents for cancer therapy: what do we know? 10.3390/cancers13133193 Chem. Science Pollok 11 12386 2020 Electro-organic synthesis–a 21 st century technique 10.1039/d0sc01848a Open Med. Chem. J. Qadir 16 e187410452202280 2022 A review on medicinally important heterocyclic compounds 10.2174/18741045-v16-e2202280 Drug Res. Ramesh 73 491 2023 A review of PARP-1 inhibitors: assessing emerging prospects and tailoring therapeutic strategies 10.1055/a-2181-0813 Arch. Pharm. Reddy 355 2200214 2022 Drug re‐engineering and repurposing: a significant and rapid approach to tuberculosis drug discovery 10.1002/ardp.202200214 Int. J. Mol. Sci. Rizzo 24 7728 2023 FDA-approved fluorinated heterocyclic drugs from 2016 to 2022 10.3390/ijms24097728 Expert Opin. Drug Discov. Sánchez 18 1413 2023 Advances in the discovery of heterocyclic-based drugs against Alzheimer’s disease 10.1080/17460441.2023.2264766 Eur. J. Med. Chem. Sharma 200 112438 2020 Recent advancements in the development of heterocyclic anti-inflammatory agents 10.1016/j.ejmech.2020.112438 The future perspectives of drug repurposing and treatment for the drug resistant breast cancer, drug repurposing: molecular aspects and therapeutic applications Theivendren 139 2022 Nanotechnology Theivendren 36 2025 Emerging therapeutic strategies and opportunities in targeting protein pathways for breast cancer treatment: a critical review 10.1088/1361-6528/add6ae Green Chem. Verma 26 4270 2024 Principles and theories of green chemistry for corrosion science and engineering: design and application 10.1039/d3gc05207a Food Res. Int. Wang 127 108628 2020 Green tea polyphenols and epigallocatechin-3-gallate protect against perfluorodecanoic acid induced liver damage and inflammation in mice by inhibiting NLRP3 inflammasome activation 10.1016/j.foodres.2019.108628 Amino acids: insights and roles in heterocyclic chemistry: volume 2: hydantoins, thiohydantoins, and 2, 5-Diketopiperazines Wang 2023 10.1201/9781003329831 Signal Transduct. Target. Ther. Wang 6 423 2021 An overview of kinase downregulators and recent advances in discovery approaches 10.1038/s41392-021-00826-7 Food Hydrocolloids Zhang 108 106073 2020 Inhibitory effects of some hydrocolloids on the formation of heterocyclic amines in roast beef 10.1016/j.foodhyd.2020.106073 Food Chem. Zhang 375 131859 2022 Chitosan and flavonoid glycosides are promising combination partners for enhanced inhibition of heterocyclic amine formation in roast beef 10.1016/j.foodchem.2021.131859